Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,145-18,156 of 23,847
Drug study icon
CompletedNCT00884897

Oxytocin and Social Cognition in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Catonsville
Schizophrenia, AnxietyDrugA study involving a medication or substance.From 18 Years to 55 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia, Anxiety
Drug study icon
CompletedNCT04176835

Oxytocin and Social Decision Making in Schizophrenia

This study exists to see whether brain scans or other body measurements can make care clearer and more responsive. Researchers are trying to understand whether brain scans or other body measurements can give earlier or clearer feedback during care.

Location not clearly listed
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Condition
Schizophrenia
Behavioral study icon
CompletedNCT03610633

Oxytocin and Stress Response in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
AddictionBehavioralFrom 21 Years to 40 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT01699997

Oxytocin as Adjunctive Therapy for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Urbino
SchizophreniaDrugFrom 18 Years to 45 Years
Countries
Italy
Sponsor
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Condition
Schizophrenia
Drug study icon
CompletedNCT01568528

Oxytocin as Adjunctive Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Decatur
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Emory University
Condition
Schizophrenia
Drug study icon
CompletedNCT02881177

Oxytocin HIV Meth Study

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Addiction
Drug study icon
WithdrawnNCT02711189

Oxytocin in Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
AddictionDrugFrom 21 Years to 55 Years
Countries
Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Condition
Addiction
Drug study icon
CompletedNCT01573273

Oxytocin in Cocaine Dependence

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
AddictionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
OngoingEUCTR 2012-003072-39

Oxytocin in PTSD: effectiveness as addition to Narrative Exposure Therapy

This study is looking at whether Syntocinon, nasal spray 40 IU/ml can help people with PTSD. Participants receive the study medicine Syntocinon, nasal spray 40 IU/ml and complete study visits and assessments.

In Netherlands
PTSDOther
Countries
Netherlands
Sponsor
Academic Medical Center, University of Amsterdam
Condition
PTSD
Drug study icon
CompletedNCT02568709

Oxytocin MEG Study

This summary needs review. Please check the official study record and contact the research team for details.

In San Francisco
SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Schizophrenia
Drug study icon
WithdrawnNCT03865615

Oxytocin on Approach Bias and Craving

This summary needs review. Please check the official study record and contact the research team for details.

In Berkeley
AddictionDrugFrom 21 Years to 40 Years
Countries
United States
Sponsor
Jennifer Mitchell
Condition
Addiction
Drug study icon
CompletedNCT01012167

Oxytocin or Galantamine Versus Placebo for Negative Symptoms and Cognitive Impairments in Schizophrenia

This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.

Multiple locations, including Baltimore
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.